Found 4 matching trials
Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency
PHASE3This is a Phase 3 study to assess the safety and efficacy of Tadekinig alfa...
Location
UCSD _ Department of Pediatrics / Rady Children's Hospital
Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency As Open Label Extension
PHASE3This is an open-label extension study for patients previously enrolled in t...
Location
UCSD _ Department of Pediatrics / Rady Children's Hospital
Tadekinig Alfa (IL-18BP) Rescue Therapy for CAR T Cell Related Cytokine Release Syndrome (CRS) and HLH-like Syndrome
EARLY_PHASE1This is a pilot, open-label study to assess the safety and feasibility of u...
Location
University of Pennsylvania
Therapeutic Use of Tadekinig Alfa in Adult-onset Still's Disease
PHASE2The objective of this study is to assess safety, tolerability and early sig...
Location
Hôpital Pellegrin